These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10304638)

  • 1. Patient package insert lands in courts.
    Lawrence SV
    Bull Am Coll Physicians; 1977 Nov; 18(11):7-8, 10, 12 passim. PubMed ID: 10304638
    [No Abstract]   [Full Text] [Related]  

  • 2. The package insert and the pharmacist's liability.
    Simonsmeier LM
    Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428
    [No Abstract]   [Full Text] [Related]  

  • 3. A means to provide patient education: "Rx package inserts, patient package inserts, device labeling".
    Sherman M
    ONA J; 1979 Aug; 6(8):326-9. PubMed ID: 257297
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 5. The legal status of patient package inserts.
    Whitman JA
    Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
    [No Abstract]   [Full Text] [Related]  

  • 6. The patient package insert and its legal implications.
    Cook D
    Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797
    [No Abstract]   [Full Text] [Related]  

  • 7. Package inserts, adverse drug reactions, and the physician's liability.
    Morrell MX
    Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient package inserts: a research perspective.
    Morris LA; Groft SC
    Drug Ther; 1982; ():191-217. PubMed ID: 7105993
    [No Abstract]   [Full Text] [Related]  

  • 9. The patient package insert--an ethical dilemma.
    Braucher CL
    Am J Pharm Educ; 1981 Feb; 45(1):61-6. PubMed ID: 10251227
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient package insert--legal perspective.
    Hirsh HL
    Leg Med Q; 1979; 3(1):31-4. PubMed ID: 10245004
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA proposes that patient package insert program be rescinded.
    Hospitals; 1982 Feb; 56(4):84. PubMed ID: 7054117
    [No Abstract]   [Full Text] [Related]  

  • 12. History of FDA patient package insert requirements.
    Am J Hosp Pharm; 1980 Dec; 37(12):1660-1. PubMed ID: 7004180
    [No Abstract]   [Full Text] [Related]  

  • 13. The package insert.
    JAMA; 1969 Feb; 207(7):1342. PubMed ID: 5818327
    [No Abstract]   [Full Text] [Related]  

  • 14. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 15. Notes on the package insert.
    JAMA; 1969 Feb; 207(7):1335-8. PubMed ID: 5818325
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient package insert requirements. Statement of the American Society of Internal Medicine.
    J Indiana State Med Assoc; 1982 Feb; 75(2):126-7. PubMed ID: 7069200
    [No Abstract]   [Full Text] [Related]  

  • 17. Should a specially prepared package insert be made available to patients?
    Schidt AM; Sammons JH
    J Fla Med Assoc; 1975 Sep; 62(9):54-5. PubMed ID: 1159381
    [No Abstract]   [Full Text] [Related]  

  • 18. The medicolegal significance of the package insert.
    Hirsh HL
    J Fam Pract; 1977 Jun; 4(6):1141-3. PubMed ID: 874441
    [No Abstract]   [Full Text] [Related]  

  • 19. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 20. The medicolegal significance of the package insert.
    Hirsh HL
    Conn Med; 1978 Dec; 42(12):785-8. PubMed ID: 720048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.